NCT06768541

Brief Summary

Total hip arthroplasty (THA) is a widely accepted procedure for the treatment of end-stage hip osteoarthritis. Neck preserving short stems have gained popularity in recent years, as they aim to preserve proximal femoral bone stock and enable a more physiological load transfer. However, the use of these stems in patients with specific femoral deformities, such as DORR Type C femurs, can present unique challenges. DORR Type C femurs are characterized by decreased cortical bone thickness and increased medullary canal width, which can impact the fit and stability of the femoral stem component. Short stem total hip arthroplasty has emerged as a potential solution for these patients, as it aims to preserve proximal femoral bone stock and improve load transfer to the surrounding bone. This study seeks to investigate the measured subsidence of short stem total hip arthroplasty in patients with DORR Type C femur configuration and the clinical outcomes associated with this approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 10, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

1.6 years

First QC Date

December 1, 2024

Last Update Submit

March 11, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stem Subsidence

    Subsidence of the femoral stem, measured in mm

    2 years

Secondary Outcomes (3)

  • HHS

    2 years

  • OHS

    2 years

  • SF-12

    2 years

Study Arms (1)

Dorr C Hip

Patients who received short stem THA with a Dorr C configuration of the femur

Procedure: THA using a short stem

Interventions

Total Hip Arthroplasty using a collarless, triple-tapered cementless short stem (Optimys, produced by Mathys).

Dorr C Hip

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

108 patients were eligible, of which 55 underwent routine follow-ups. Complete data was available from 44 patients. 22 patients each were male and female. Mean age at surgery was 68.3 years. Mean BMI was 27.9 kg/m2

You may qualify if:

  • THA using Optimys short stem from 1.1.2018 bis 31.12.2020 in the institution.
  • Typ C Femur according to Dorr

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ordensklinikum Linz Barmherzige Schwestern

Linz, 4010, Austria

Location

MeSH Terms

Conditions

Osteoarthritis, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2024

First Posted

January 10, 2025

Study Start

January 1, 2023

Primary Completion

July 31, 2024

Study Completion

March 31, 2025

Last Updated

March 12, 2026

Record last verified: 2026-03

Locations